Tembusu Tembusu Holdings reduced its stake in INNOVENT BIO (01801) by 3,048,500 shares at a price of approximately HK$51.98 per share.
On April 25, Temasek Holdings reduced its stake in Sino Biopharmaceutical (01801) by 3,048,500 shares, with a price of 51.9847 Hong Kong dollars per share, totaling approximately 158 million Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on April 25, Temasek Holdings reduced its holdings of INNOVENT BIO (01801) by 3.0485 million shares, with each share priced at 51.9847 Hong Kong dollars, for a total amount of approximately 158 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 115 million shares, with a new shareholding ratio of 6.96%.
RECOMMEND
Goldman Sachs: Strong performance by tech giants boosts confidence, recent pullback provides a good opportunity to buy into the US AI sector.
06/05/2025
Hong Kong's foreign exchange reserves have once again reached a strong level, with the Hong Kong Monetary Authority subsequently selling $7.812 billion.
06/05/2025
Berkshire Hathaway Shareholders Meeting Q&A Live: Buffett Talks about Trade, Japan, and Cash Deployment in 2025.
03/05/2025
